Tekla Capital Management LLC Charles River Laboratories International, Inc. Transaction History

Tekla Capital Management LLC

$2.53 Billion
Q2 2023

A detailed history of Tekla Capital Management LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Tekla Capital Management LLC holds 111,183 shares of CRL stock, worth $21.8 Million. This represents 0.93% of its overall portfolio holdings.

Number of Shares

111,183

Previous 118,083 5.84%

Holding current value

$21.8 Million

Previous $23.8 Million 1.91%

% of portfolio

0.93%

Previous 0.91%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	SELL	$183.71 - $210.25 $1.27 Million - $1.45 Million	-6,900 Reduced 5.84%	111,183 $23.4 Million
Q1 2023 May 10, 2023	BUY	$191.89 - $259.92 $8.71 Million - $11.8 Million	45,408 Added 62.48%	118,083 $23.8 Million
Q3 2022 Nov 01, 2022	BUY	$182.44 - $250.54 $4.52 Million - $6.21 Million	24,781 Added 51.74%	72,675 $14.3 Million
Q2 2022 Jul 29, 2022	SELL	$204.13 - $302.4 $2.88 Million - $4.26 Million	-14,096 Reduced 22.74%	47,894 $10.2 Million
Q4 2021 Feb 14, 2022	SELL	$351.38 - $448.68 $5.8 Million - $7.4 Million	-16,494 Reduced 21.02%	61,990 $23.4 Million
Q3 2021 Nov 12, 2021	BUY	$372.64 - $458.3 $8.87 Million - $10.9 Million	23,810 Added 43.55%	78,484 $32.4 Million
Q2 2021 Aug 13, 2021	BUY	$294.17 - $371.65 $3.41 Million - $4.31 Million	11,600 Added 26.93%	54,674 $20.2 Million
Q1 2021 May 14, 2021	BUY	$249.67 - $299.48 $3.73 Million - $4.47 Million	14,920 Added 52.99%	43,074 $12.5 Million
Q4 2020 Feb 12, 2021	SELL	$222.0 - $252.62 $577,200 - $656,812	-2,600 Reduced 8.45%	28,154 $7.04 Million
Q3 2020 Nov 13, 2020	BUY	$175.56 - $226.45 $2.16 Million - $2.78 Million	12,287 Added 66.53%	30,754 $6.96 Million
Q1 2020 May 14, 2020	SELL	$98.9 - $178.34 $247,250 - $445,850	-2,500 Reduced 11.92%	18,467 $2.33 Million
Q4 2019 Feb 13, 2020	SELL	$126.05 - $152.76 $516,805 - $626,316	-4,100 Reduced 16.36%	20,967 $3.2 Million
Q3 2019 Nov 13, 2019	BUY	$125.07 - $143.67 $1.36 Million - $1.57 Million	10,900 Added 76.94%	25,067 $3.32 Million
Q2 2019 Aug 14, 2019	BUY	$123.4 - $148.55 $435,231 - $523,935	3,527 Added 33.15%	14,167 $2.01 Million
Q1 2019 May 14, 2019	SELL	$104.82 - $146.73 $1.26 Million - $1.77 Million	-12,030 Reduced 53.07%	10,640 $1.55 Million
Q1 2018 May 14, 2018	SELL	$98.19 - $115.2 $6.2 Million - $7.27 Million	-63,134 Reduced 73.58%	22,670 $2.42 Million
Q4 2017 Feb 14, 2018	SELL	$100.43 - $118.09 $4.15 Million - $4.88 Million	-41,296 Reduced 32.49%	85,804 $9.39 Million
Q2 2017 Aug 14, 2017	BUY	N/A	127,100	127,100 $12.9 Million

Others Institutions Holding CRL

# of Institutions

696

Shares Held

52.3M

Call Options Held

259K

Put Options Held

463K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.96B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tekla Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tekla Capital Management LLC with notifications on news.

Account

Tekla Capital Management LLC Charles River Laboratories International, Inc. Transaction History